No­vo in­vests $6B+ to ex­pand man­u­fac­tur­ing fa­cil­i­ties as de­mand for We­govy sky­rock­ets

No­vo Nordisk is in­vest­ing more than DKK 42 bil­lion ($6 bil­lion) to ex­pand its ex­ist­ing man­u­fac­tur­ing fa­cil­i­ties in Den­mark, most­ly to in­crease its ac­tive phar­ma­ceu­ti­cal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER